Cargando…
An Update in the Use of Antibodies to Treat Glioblastoma Multiforme
Glioblastoma is a deadly brain disease and modest improvement in survival has been made. At initial diagnosis, treatment consists of maximum safe surgical resection, followed by temozolomide and chemoirradiation or adjuvant temozolomide alone. However, these treatments do not improve the prognosis a...
Autores principales: | Hernández-Pedro, Norma Y., Rangel-López, Edgar, Vargas Félix, Gustavo, Pineda, Benjamín, Sotelo, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835613/ https://www.ncbi.nlm.nih.gov/pubmed/24294521 http://dx.doi.org/10.1155/2013/716813 |
Ejemplares similares
-
Production and Evaluation of an Avian IgY Immunotoxin against CD133+ for Treatment of Carcinogenic Stem Cells in Malignant Glioma: IgY Immunotoxin for the Treatment of Glioblastoma
por: Chavez-Cortez, Elda-Georgina, et al.
Publicado: (2019) -
An update of advanced nanoplatforms for Glioblastoma Multiforme Management
por: Amaral, Mariana, et al.
Publicado: (2021) -
Role of Redox Status in Development of Glioblastoma
por: Salazar-Ramiro, Aleli, et al.
Publicado: (2016) -
Update and developments in the treatment of glioblastoma multiforme – focus on bevacizumab
por: Wagle, Naveed, et al.
Publicado: (2010) -
Glioblastoma Multiforme in the over 70's: “To treat or not to treat with radiotherapy?”
por: Glynn, Aisling M., et al.
Publicado: (2019)